共 15 条
[2]
帕金森病发病机制与治疗研究十年进展[J]. 汪锡金,张煜,陈生弟.中国现代神经疾病杂志. 2010(01)
[4]
The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson’s disease: A multicenter, double-blind, randomized, placebo-controlled study[J] . Zhenxin Zhang,Jian Wang,Xiaoying Zhang,Shengdi Chen,Zhenfu Wang,Baorong Zhang,Chunfeng Liu,Qiumin Qu,Yan Cheng,Jie Li,Haijun Cao,Meng Cai,Rongxuan Zhu.Parkinsonism and Related Disorders . 2013 (11)
[5]
Integrated multidisciplinary care in Parkinson’s disease: a non-randomised, controlled trial (IMPACT)[J] . Marjolein A van der Marck,Marten Munneke,Wim Mulleners,Edo M Hoogerwaard,George F Borm,Sebastiaan Overeem,Bastiaan R Bloem.Lancet Neurology . 2013 (10)
[6]
Inhaled dry powder apomorphine ( VR 040) for ‘off ’ periods in P arkinson’s disease: an in‐clinic double‐blind dose ranging study[J] . K. A. Grosset,N. Malek,F. Morgan,D. G. Grosset.Acta Neurol Scand . 2013 (3)
[7]
Disease duration-related differences in non-motor symptoms: A study of 616 Chinese Parkinson’s disease patients[J] . Xiaoyan Guo,Wei Song,Ke Chen,XuePing Chen,Zhenzhen Zheng,Bei Cao,Rui Huang,Bi Zhao,Ying Wu,Hui-Fang Shang.Journal of the Neurological Sciences . 2013 (1-2)
[8]
Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer’s, Parkinson’s and prion diseases[J] . John H. Viles.Coordination Chemistry Reviews . 2012 (19-2)
[9]
Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases[J] . Wei Zheng,Andrew D. Monnot.Pharmacology and Therapeutics . 2011 (2)
[10]
Effect of rotigotine on sleep and quality of life in Parkinson’s disease patients: post hoc analysis of RECOVER patients who were symptomatic at baseline[J] . Liesbet Ghys,Erwin Surmann,John Whitesides,Babak Boroojerdi.Expert Opinion on Pharmacotherapy . 2011 (13)